Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-43
Closed -$821 – 1072
2025
Q1
$821 Hold
43
– – ﹤0.01% 940
2024
Q4
$1.02K Hold
43
– – ﹤0.01% 919
2024
Q3
$1.2K Buy
+43
New +$1.21K ﹤0.01% 844
2024
Q1
– Sell
-73
Closed -$1.7K – 846
2023
Q4
$1.7K Hold
73
– – ﹤0.01% 685
2023
Q3
$1.44K Hold
73
– – ﹤0.01% 609
2023
Q2
$1.66K Buy
+73
New +$1.47K ﹤0.01% 610
2023
Q1
– Sell
-73
Closed -$1.26K – 899
2022
Q4
$1.26K Buy
+73
New +$1.29K ﹤0.01% 805

Other funds holding RXO

Truvestments Capital's RXO Position: Q2 2025 in Review

Truvestments Capital sold out of RXO (RXO) in Q2 2025, closing a stake of 43 shares — an estimated $821 sold.

Truvestments Capital first reported a position in RXO in Q4 2022 and held it in 7 quarters. The position peaked at $1.7K in Q4 2023. 268 funds tracked by Wall St. Rank hold RXO as of Q2 2025.

  • Truvestments Capital reported no remaining RXO position as of Q2 2025 after selling out during the quarter.
  • Truvestments Capital sold 43 RXO shares in Q2 2025, an estimated $821.
  • Truvestments Capital first reported a position in RXO in Q4 2022 and held it in 7 quarters.
  • Truvestments Capital's RXO position peaked at $1.7K in Q4 2023.
  • 268 funds tracked by Wall St. Rank held RXO as of Q2 2025.

Based on Truvestments Capital's 13F filing for Q2 2025, filed 13 Aug 2025.